A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Clinical trial NCT02309892 · TERMINATED

Trial details

NCT number: NCT02309892
Sponsor: Helix BioPharma Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2015-04-20
Primary completion: 2019-08-19
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.